OnCore Login
network member

Mayo Clinic

200 First Street SW, Rochester, MN 55905

About Network Member

Website: Mayo Clinic
https://www.mayo.edu/research/clinical-trials
Currently Enrolling

HCRN-GI18-333

Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and gastroesophageaL junction (GEJ) adenocarcinoma (SEQUEL)
Harry H. Yoon
Cancer areas:GastricGastroesophageal Junction
Froedtert & the Medical College of Wisconsin
Mayo Clinic
Learn More
See clinicaltrials.gov
Currently Enrolling

TBCRC047

Innovative Combination Immunotherapy for Metastatic Triple Negative Breast Cancer (TNBC): A Multicenter, Multi-Arm Translational Breast Cancer Research Consortium Study
Hope Rugo
Cancer areas:Breast
Dana-Farber Cancer Institute
Duke Cancer Institute
Georgetown Lombardi Comprehensive Cancer Center
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The University of Chicago Medicine Comprehensive Cancer Center
UC San Francisco
University of Alabama at Birmingham Comprehensive Cancer Center
University of North Carolina Lineberger Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Learn More
See clinicaltrials.gov
Enrollment Closed

HCRN-MEL16-252

Single Arm Phase II Study of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma (SALVO Study). HCRN: MEL16-252
Robert R. McWilliams
Cancer areas:Melanoma
Fox Chase Cancer Center
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Nebraska Cancer Specialists
Providence Cancer Institute
University of Iowa Holden Comprehensive Cancer Center
Learn More
See clinicaltrials.gov
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278